Experimental development of a degradable nanocarrier enhances targeted drug delivery in cancer therapy, suggesting improved treatment efficacy.
No takes yet. Share an insight, caveat, or question.
Banerjee et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: